Sharon Mermis

Company: Emris Pharma

Job title: CSO & Co-Founder

Seminars:

Transforming Supportive Oncology Care: Innovative Skin-Directed Targeted Therapies for EGFR Inhibitor Induced Inflammation 11:30 am

First-in-Class Skin-Directed Prevention — blocking EGFRi on-target toxicities before skin inflammation occurs. Follicular-Focused Drug Delivery — maximizing local efficacy while minimizing systemic exposure. Targeting Rare Dermatologic Diseases — addressing high unmet medical need with limited treatment options.Read more

day: Day Two AM